These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24605967)

  • 1. A multiple imputation method for sensitivity analyses of time-to-event data with possibly informative censoring.
    Zhao Y; Herring AH; Zhou H; Ali MW; Koch GG
    J Biopharm Stat; 2014; 24(2):229-53. PubMed ID: 24605967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening the interpretability of clinical trial results by assessing the effect of informative censoring on the primary estimand in PRECISION.
    Bao W; Gaffney M; Pressler ML; Fayyad R; Wisemandle W; Beckerman B; Wolski KE; Nissen SE
    Clin Trials; 2020 Oct; 17(5):535-544. PubMed ID: 32643966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference-based sensitivity analysis for time-to-event data.
    Atkinson A; Kenward MG; Clayton T; Carpenter JR
    Pharm Stat; 2019 Nov; 18(6):645-658. PubMed ID: 31309730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonparametric comparison of two survival functions with dependent censoring via nonparametric multiple imputation.
    Hsu CH; Taylor JM
    Stat Med; 2009 Feb; 28(3):462-75. PubMed ID: 18991250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of colorectal adenoma recurrence with dependent censoring.
    Hsu CH; Long Q; Alberts DS
    BMC Med Res Methodol; 2009 Sep; 9():66. PubMed ID: 19788750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimension reduction in survival regressions with censored data via an imputed spline approach.
    Lue HH; Chen CH; Chang WH
    Biom J; 2011 May; 53(3):426-43. PubMed ID: 21495063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using cure models and multiple imputation to utilize recurrence as an auxiliary variable for overall survival.
    Conlon AS; Taylor JM; Sargent DJ; Yothers G
    Clin Trials; 2011 Oct; 8(5):581-90. PubMed ID: 21921063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment.
    Zhao Y; Saville BR; Zhou H; Koch GG
    J Biopharm Stat; 2016; 26(2):269-79. PubMed ID: 25635808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis using auxiliary variables via non-parametric multiple imputation.
    Hsu CH; Taylor JM; Murray S; Commenges D
    Stat Med; 2006 Oct; 25(20):3503-17. PubMed ID: 16345047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity analyses for informative censoring in survival data: A trial example.
    Liu Y
    J Biopharm Stat; 2017; 27(4):595-610. PubMed ID: 27010683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measures of follow-up in time-to-event studies: Why provide them and what should they be?
    Betensky RA
    Clin Trials; 2015 Aug; 12(4):403-8. PubMed ID: 26025565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of the discrete-time Kaplan-Meier estimate to nonignorable censoring: Application in a clinical trial.
    Liu T; Heitjan DF
    Stat Med; 2012 Nov; 31(25):2998-3010. PubMed ID: 22806989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.
    Hsu CH; Taylor JM; Hu C
    Stat Med; 2015 Aug; 34(19):2768-80. PubMed ID: 25999295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control-based imputation for sensitivity analyses in informative censoring for recurrent event data.
    Gao F; Liu GF; Zeng D; Xu L; Lin B; Diao G; Golm G; Heyse JF; Ibrahim JG
    Pharm Stat; 2017 Nov; 16(6):424-432. PubMed ID: 28834175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple parametric survival analysis with anonymized register data: A cohort study with truncated and interval censored event and censoring times.
    Støvring H; Kristiansen IS
    BMC Res Notes; 2011 Aug; 4():308. PubMed ID: 21867515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hidden Imputations and the Kaplan-Meier Estimator.
    Cole SR; Edwards JK; Naimi AI; Muñoz A
    Am J Epidemiol; 2020 Nov; 189(11):1408-1411. PubMed ID: 32412079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of informative censoring on the Kaplan-Meier estimate of progression-free survival in phase II clinical trials.
    Campigotto F; Weller E
    J Clin Oncol; 2014 Sep; 32(27):3068-74. PubMed ID: 25113767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of colorectal adenoma recurrence data subject to informative censoring.
    Hsu CH; Taylor JM; Long Q; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):712-7. PubMed ID: 19240239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a Counting Process Method to Impute Censored Follow-Up Time Data.
    Efird JT; Jindal C
    Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29621186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of censoring on progression free survival: oncologist discretion advised.
    Prasad V; Bilal U
    Eur J Cancer; 2015 Nov; 51(16):2269-71. PubMed ID: 26259493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.